Idled Hospira plant now back online with new management

Hospira ($HSP) stock gained after the company announced its Rocky Mount, NC, plant had resumed operations and reached 60% to 70% capacity, which is close to normal levels. The plant had been closed for revamping after FDA inspectors identified repeated manufacturing violations. It's now under new management who are working on more changes to "processes and procedures," the company said. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.